LATEST NEWS

Category Archives: Company

Vesalius Biocapital III Partners joins Forendo Pharma Investor Syndicate

Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women’s health, today announces that it has raised an additional €4 million of funding from Vesalius Biocapital III Partners (Vesalius III). This is in addition to the €12 million Series A financing in 2014 and €5,7 million R&D loans granted by Business […]

Forendo receives clinical trial authorization to initiate phase I study

Forendo Pharma has received clinical trial authorization (CTA) from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to commence a study for its lead program, FOR-6219. Endometriosis is a chronic condition that affects up to 10% of women in reproductive age and causes repeated pain symptoms, infertility and impaired quality of life. Currently available […]

Forendo receives €3 million loan from Business Finland

Business Finland grants Forendo Pharma a €3 million R&D loan for the development of a new drug for endometriosis treatment. The funding from Business Finland will enable Forendo to strengthen its women’s health portfolio, by progressing its early stage DUAL HSD Inhibitor program, targeting broader gynaecological conditions, including endometriosis, into preclinical development. The DUAL HSD […]

David Colpman joins the Board of Directors of Forendo Pharma

Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, today announces the appointment of David Colpman as a non-executive director to its Board of Directors. David brings with him an impressive career of more than 25 years in pharma and biotech business development and strategy. His previous roles include Head of […]

Scrip Pharmaceuticals profiles Forendo Pharma

Forendo Pharma CEO, Risto Lammintausta, was interviewed by Scrip Pharmaceuticals for an Emerging Company Profile section of the publication: “Forendo Pharma: Tackling The Endometriosis Challenge”. Get pdf version of the Scrip article by clicking here SCRIP is a leading source of news and strategic analysis for the global pharmaceutical industry, with over 14,000 registered users […]

Forendo Pharma nominates world class scientific advisory board and elects Professor Linda Giudice as the chairperson

Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, announces the nomination of its Scientific Advisory Board today. Forendo is developing tissue-specific hormone inhibitors to rebalance local estrogen metabolism in endometrial tissues. The key differentiator of the company’s lead HSD17B1 inhibitor compared to other drug treatments is the ability to act […]

Forendo awarded at the European Venture Summit

Forendo Pharma was one of the Top 25 Award Winners of the European Venture Contest in Dusseldorf, Germany. Forendo was presented by Maarit Merla, Head of Business Development. European Venture Summit Award Winners Over 100 investors and business angels chose the Top 25 emerging companies of the 2016 European Venture Contest at the continent’s biggest […]

Forendo in the Team Finland Health portal

Forendo Pharma is in the Team Finland Health portal of Finpro, Finland’s Trade and Investment Promotion Agency. Finlandhealth.fi represents the entire Finnish health care sector’s know-how through one digital portal and presents a comprehensive view and specific set of health care offerings from Finland. The website can be found at http://www.finlandhealth.fi/ and it is constantly updated. […]

Meet us in Stockholm during Bio-Europe Spring

Forendo Pharma will participate in the BIO-Europe Spring® partnering conference in Stockholm, Sweden, during April 4th to 6th 2016. We will be meeting with potential licensing partners for our Fispemifene program. In order to schedule a meeting with us, please use the conference PartneringONE system or send us a message: businesscontacts@forendo.com We look forward to seeing […]

Forendo selected one of the most promising start-up companies in Finland

Forendo Pharma was selected as one of 20 most promising start-up companies in Finland, by Talouselämä, a highly respected finance magazine in Finland. Talouselämä is the only finance magazine published weekly in Finland and also the largest of its kind within the Nordic market. The selection of the most promising start-up companies was based on […]